Provided by Tiger Fintech (Singapore) Pte. Ltd.

Icon Energy Corp.

1.90
-0.0900-4.52%
Pre-market: 1.930.0300+1.58%08:27 EDT
Volume:77.23K
Turnover:148.38K
Market Cap:4.15M
PE:0.16
High:1.98
Open:1.92
Low:1.86
Close:1.99
Loading ...

Press Release: ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

Dow Jones
·
29 Jan

ICON (NASDAQ:ICLR) shareholders have endured a 24% loss from investing in the stock a year ago

Simply Wall St.
·
28 Jan

Icon Energy Corp. Completes $12 Million Public Offering

TIPRANKS
·
28 Jan

BRIEF-Icon Energy Corp. Announces Closing Of Upsized $12.0 Million Public Offering

Reuters
·
25 Jan

Press Release: ICON Energy Corp. Announces Closing of Upsized $12.0 Million Public Offering

Dow Jones
·
25 Jan

Icon Energy prices 9.16M units at $1.31 in upsized public offering

TipRanks
·
24 Jan

Icon Energy Third Quarter 2024 Earnings: US$0.69 loss per share (vs US$0.32 profit in 3Q 2023)

Simply Wall St.
·
24 Jan

Top Midday Decliners

MT Newswires Live
·
24 Jan

US Stocks Mixed; GE Aerospace Posts Upbeat Earnings

Benzinga
·
23 Jan

ICON Energy Corp. Announces Pricing of Upsized $12.0 Million Public Offering

THOMSON REUTERS
·
23 Jan

ICON Energy Corp. Announces Pricing of Upsized $12.0 Million Public Offering

GlobeNewswire
·
23 Jan

ICON Energy Corp Files for Offering on Best Efforts Basis of up to 4.7 Mln Units -SEC Filing

THOMSON REUTERS
·
21 Jan

These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Simply Wall St.
·
15 Jan

ICON Reaffirms 2024 Outlook, Provides 2025 Guidance; Shares Down Pre-Bell

MT Newswires Live
·
14 Jan

ICON plc Announces 2025 Financial Guidance Amid Market Challenges

TIPRANKS
·
14 Jan

Icon sees FY25 adjusted EPS $13.00-$15.00, consensus $14.93

TIPRANKS
·
14 Jan

Press Release: ICON Issues Financial Guidance for Full Year 2025

Dow Jones
·
14 Jan

What Makes ICON Public Limited Company (ICLR) a High-Quality Contender in the CRO Industry?

Insider Monkey
·
13 Jan

What Makes ICON Public Limited Company (ICLR) a Prospective Investment?

Insider Monkey
·
08 Jan

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

Business Wire
·
08 Jan